Kendra Goldhirsch is an Associate at the Firm. Ms. Goldhirsch is a 2015 New York Metro Super Lawyers Rising Star. Her practice focuses on national product liability litigation and mass torts.
Express Scripts continues to exclude diabetes drug Onglyza from its preferred formulary, listing it as an exclusion for 2017. The prescription benefit plan provider first dropped the medication from its list last year, when it announced that it would no longer provide insurance coverage for…
Proton pump inhibitors (PPIs) like Nexium and Prilosec have been linked in recent studies to a number of potentially dangerous side effects, including bone fractures and chronic kidney disease. A new case study, however, suggests that there may be other concerns, namely, “rhabdomyolysis”, a skeletal
The FDA announced a recall of the Olympus TJF-Q180V duodenoscope on January 15, 2016. The medical and surgical products company stated that it was recalling the product to update it with a new design and labeling modifications meant to reduce the risk of superbug infections…
The Centers for Disease Control and Prevention (CDC) has warned that serious gastrointestinal infections from the bacteria Clostridium difficile (or C. diff) have affected nearly half a million people in 2011, with 29,000 dying within 30 days of the initial diagnosis. C. diff. has become…
On July 13, 2016, a Kentucky family filed a new lawsuit against the manufacturers of Onglyza, a type 2 diabetes drug. They claim that after the husband took the drug, he suffered from serious injuries. The filed the case in the Eastern District of Kentucky,…
On July 19, 2016, the Cook IVC MDL court selected three cases that will be the first to go to trial in the consolidated federal litigation. In October 2014, all Cook IVC filter lawsuits were consolidated into one court in the Southern District of Indiana.…
All federal testosterone replacement therapy lawsuits were consolidated in one court in June 2014. They are now proceeding in the Northern District of Illinois, before District Court Judge Matthew Kennelly. Both sides have been preparing a small group of cases for early trial. These are…
On June 14, 2016, the Food and Drug Administration (FDA) released another safety communication concerning the type 2 diabetes medication, Invokana (canagliflozin). It warned physicians and patients that Invokana and other similar medications (like Farxiga and Xigduo XR) can increase the risk of seri
According to a new study, heartburn drugs like Nexium and Prilosec may increase risk of osteoporosis—a disease in which the bones become weak and brittle and prone to fracture. A study in the journal of International Journal of Rheumatic Diseases, has raised more concerns about…
The FDA announced in January 2016 that Olympus America was recalling its TJF-Q180V duodenoscope because of concerns about contamination leading to serious antibiotic-resistant bacterial infections. In an effort to reduce the risk of infection, Olympus updated the product with a new design and labeli
The FDA has released a new warning concerning the type 2 diabetes drug, Invokana (canagliflozin). A year ago, they released a previous safety communication warning doctors and patients that Invokana could increase risk of diabetic ketoacidosis (DKA), a serious condition in which the blood becomes…
In early 2014, the FDA warned about study results that suggested the type 2 diabetes drug Onglyza could be linked to the risk of heart failure. In April 2015, the FDA scheduled an advisory panel meeting of the Endocrinologic and Metabolic Drugs Advisory Committee to…